GRACE (Gender, Race And Clinical Experience): 48-week results of darunavir/r-based therapy in the largest trial in north america to focus on treatment-experienced women

Presented at the 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town, South Africa, July 19–22, 2009. If you have any additional questions or would like a copy of this poster, call +1-877-REACH-TT (+1-877-732-2488) or go to www.ttmedinfo.com